Allarity Therapeutics, Inc. (ALLR)

NASDAQ: ALLR · IEX Real-Time Price · USD

1.000

-0.230 (-18.70%)

At close: May 3, 2024, 4:00 PM

1.030

+0.030 (3.00%)

After-hours: May 3, 2024, 7:59 PM EDT

Allarity Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	2	3	3	84	-	-
Market Cap Growth	-	-16.66%	-96.40%	-	-	-
Enterprise Value	4	4	5	65	2	-1
PE Ratio	-0.12	-0.12	-0.14	-3.14	-	-
PB Ratio	-0.91	-0.91	-26.68	4.62	-	-
P/FCF Ratio	-0.20	-0.20	-0.19	-6.04	-	-
P/OCF Ratio	-0.20	-0.20	-0.18	-5.63	-	-
EV/Sales Ratio	-	-	-	-	-	-4675.00
EV/EBITDA Ratio	-0.32	-0.32	-0.27	-2.64	-0.39	-8.08
EV/EBIT Ratio	-0.32	-0.32	-0.27	-2.63	-0.39	36.01
EV/FCF Ratio	-0.29	-0.29	-0.29	-4.68	-0.33	0.06
Debt / Equity Ratio	-0.47	-0.47	-33.05	0.06	0.11	0.05
Debt / EBITDA Ratio	-0.12	-0.12	-0.22	-0.04	-0.44	13.87
Debt / FCF Ratio	-0.10	-0.10	-0.23	-0.08	-0.37	-0.10
Quick Ratio	0.01	0.01	0.18	0.96	0.05	0.34
Current Ratio	0.14	0.14	0.44	1.03	0.31	0.71
Interest Coverage	-22.73	-22.73	-77.83	-13.36	-19.01	-4.70
Return on Equity (ROE)	820.30%	820.30%	-350.40%	-125.10%	-31.00%	-
Return on Assets (ROA)	-157.50%	-157.50%	-96.60%	-64.20%	-20.30%	-
Return on Capital (ROIC)	1180.50%	1180.50%	-951.49%	-138.04%	-30.69%	-0.09%
Earnings Yield	-855.56%	-812.66%	-698.34%	-31.81%	-	-
FCF Yield	-534.10%	-507.31%	-531.64%	-16.57%	-	-
Buyback Yield / Dilution	-29175.59%	-29175.59%	-49.78%	-94.02%	-160.00%	-
Total Shareholder Return	-29175.59%	-29175.59%	-49.78%	-94.02%	-160.00%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).